Surprisingly, however, deletion of c-Met in ECs does not impair normal angiogenesis, but rather leads to the formation of more normal-looking tumor blood vessels, and reduces hemorrhaging and necrosis, key features of aggressive GBM. The gene discussed is MET; the disease is glioblastoma.